REVS Fact Sheet: Columbia Research Enhanced Value ETF
Share
$33.87
close, Nov 18, 2026
Over the year to Nov 18, 2026, REVS returned +25.2% in total and charged 0.19% a year.
- 1-year total return
- +25.2%
- IWB +11.7% to Nov 18, 2026
- Expense ratio
- 0.19%
- a year
- Net flow, 12 months to Jul 31, 2026
- +$206m
- monthly N-PORT basis to Jul 31, 2026
Growth of $10,000, 1 year
REVS $12,516 +25.2% · IWB $11,170 +11.7% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month+0.1%
3 months−0.5%
Year to date+19.8%
1 year+25.2%
3 years+74.3%
5 years+78.7%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Apple Inc8.00%
Microsoft Corp6.81%
Bank of America Corp3.85%
Chevron Corp2.73%
Altria Group Inc2.23%
Citigroup Inc1.90%
Meta Platforms Inc1.79%
Bristol-Myers Squibb Co1.79%
TJX Cos Inc1.73%
Cisco Systems Inc1.70%
REVS top ten by weight, 32.5% of the fund, of its 303 equity positions, from the holdings filed for Jul 31, 2026.
Facts
Equity fund · Tracks the Beta Advantage Research Enhanced U.S. Value Index · First traded Sep 25, 2019 · Benchmark Russell 1000 Index, measured by IWB, which tracks the same index